An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris.

Simple item page
dc.contributor.authorSaple, D Gen_US
dc.contributor.authorTorsekar, R Gen_US
dc.contributor.authorPawanarkar, Ven_US
dc.contributor.authorDhanalakshmi, U Ren_US
dc.contributor.authorRavichandran, Gen_US
dc.contributor.authorKaur, Den_US
dc.contributor.authorDongre, Nen_US
dc.contributor.authorDesai, Aen_US
dc.date.accessioned2009-05-28T08:31:37Z
dc.date.available2009-05-28T08:31:37Z
dc.date.issued2004-03-24en_US
dc.description.abstractBACKGROUND: Tazarotene is a new third generation topical acetylenic retinoid. The present study was conducted to evaluate the efficacy and safety of tazarotene gel (0.1%) in Indian patients of acne vulgaris. METHODS: The present study was a prospective, open, multicentric, phase III trial. The duration of study was 14 weeks, including a 12-week active treatment period, preceded by a 2-week washout phase. Patients applied 0.1% tazarotene gel as a thin film over the affected area once daily in the evening. The efficacy was evaluated by analyzing changes in the number of facial acne lesions and patient's and physicians' global assessment. The efficacy parameters were assessed at baseline, visits 2, 4, 8, and 12 weeks. Tolerability and safety was assessed by physical examination, laboratory parameters and evaluation of adverse events. RESULTS: A total of 126 patients in 6 centers completed the study. At the end of the 8th and 12th weeks, the mean number of inflammatory lesions reduced by 70.6% and 86.1%, non-inflammatory lesions by 81.5% and 92%, and total lesion count 75.6% and 88.8% respectively from baseline. Also, 90.7% and 93.6% of total study cases showed complete to moderate clearance of acne lesions according to physicians at the end of the 8th and 12th weeks. CONCLUSIONS: This study confirms the efficacy and safety of tazarotene gel (0.1%) in Indian patients of acne vulgaris.en_US
dc.description.affiliationGlenmark Pharmaceuticals Ltd, Mumbai.en_US
dc.identifier.citationSaple DG, Torsekar RG, Pawanarkar V, Dhanalakshmi UR, Ravichandran G, Kaur D, Dongre N, Desai A. An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris. Indian Journal of Dermatology, Venereology and Leprology. 2004 Mar-Apr; 70(2): 92-5en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/52739
dc.language.isoengen_US
dc.source.urihttps://www.ijdvl.comen_US
dc.titleAn open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Dermatology, Venereology and Leprology